Does NEPAFENAC Cause Cystoid macular oedema? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Cystoid macular oedema have been filed in association with NEPAFENAC (ILEVRO). This represents 2.4% of all adverse event reports for NEPAFENAC.
42
Reports of Cystoid macular oedema with NEPAFENAC
2.4%
of all NEPAFENAC reports
0
Deaths
1
Hospitalizations
How Dangerous Is Cystoid macular oedema From NEPAFENAC?
Of the 42 reports, 1 (2.4%) required hospitalization.
Is Cystoid macular oedema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEPAFENAC. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does NEPAFENAC Cause?
Eye pain (393)
Drug ineffective (270)
Treatment failure (208)
Vision blurred (133)
Eye irritation (67)
Visual impairment (66)
Product quality issue (57)
Liquid product physical issue (55)
Off label use (43)
Ocular hyperaemia (42)
What Other Drugs Cause Cystoid macular oedema?
PACLITAXEL (184)
RANIBIZUMAB (147)
BEVACIZUMAB (84)
DEXAMETHASONE (69)
FINGOLIMOD (66)
ADALIMUMAB (61)
HYDROXYCHLOROQUINE (60)
PREDNISONE (53)
PREDNISOLONE (40)
METHOTREXATE (39)
Which NEPAFENAC Alternatives Have Lower Cystoid macular oedema Risk?
NEPAFENAC vs NERATINIB
NEPAFENAC vs NETARSUDIL
NEPAFENAC vs NETUPITANT\PALONOSETRON
NEPAFENAC vs NEULASTA
NEPAFENAC vs NEUPOGEN